[1]
“SELECTION OF NON-SMALL CELL LUNG CANCER PATIENTS FOR INTERCALATED CHEMOTHERAPY AND TYROSINE KINASE INHIBITORS”, Radiol Oncol, vol. 51, no. 3, Sep. 2017, Accessed: Sep. 25, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/2816